检索结果-南通市图书馆

Mitomycin C and capecitabine: An additional option as an advanced line therapy in patients with metastatic colorectal cancer

引用

World Journal of Gastrointestinal Oncology 2023年第11期15卷 1913-1924页

作者： Gil Mullin Michal Sternschuss Yosef Landman Aaron Sulkes Baruch Brenner Faculty of Medicine Tel-Aviv UniversityTel Aviv 6997801Israel Institute of Oncology Davidoff Cancer CenterBeilinson CampusPetah-Tikva 4941492Israel

BACKGROUND In recent years survival of patients with metastatic colorectal cancer(mCRC),though still limited,has improved significantly;clearly,when the disease becomes refractory to standard regimens,additional treatment options are *** have shown that mitomycin C(MMC),an antitumor antibiotic,and capecitabine,a precursor of 5-fluorouracil,may act synergistically in *** efficacy of MMC/capecitabine has been demonstrated in the first-line setting,but only a few small studies have tested it in the advanced-line setting,with contradictory *** a median of 2 MMC/capecitabine cycles(range 0.5-9.0).Thirty-four patients(28.6%)experienced grade≥3 toxicity,including 2(1.7%)with grade 4;there was no drug-related *** objective response rate was 0.8%,and the disease control rate,24.4%.Median progression-free survival(PFS)was 2.1 mo(range 0.2-20.3),and median overall survival,4.8 mo(range 0.2-27.5).The 6-month overall survival rate was 44%;8.7%of patients remained *** associated with longer PFS were lower gamma-glutamyl transferase level(P=0.030)and primary tumor location in the left colon(P=0.017).Factors associated with longer overall survival were lower gamma-glutamyl transferase level(P=0.022),left-colon tumor location(P=0.044),low-to-moderate histological grade(P=0.012),Eastern Cooperative Oncology Group performance status 0-1(P=0.036),and normal bilirubin level(P=0.047).CONCLUSION MMC/capecitabine is an active,available,and relatively safe regimen for use beyond standard lines of therapy in *** clinical and laboratory parameters can identify patients more likely to benefit.

关键词： Colorectal cancer metastatic cancer Chemotherapy Mitomycin C/Capecitabine Advanced line treatment

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Clear cell sarcoma of the pancreas,an unusual cancer with unusual metastatic site or unusual primary site?

引用

World Journal of Clinical Cases 2024年第25期12卷 5653-5656页

作者： Jhenyffer Carvalho Moreno Pedro Luiz Serrano Uson Junior Universidade 9 de Julho Sao Paulo 01509120Brazil Center for Personalized Medicine Hospital Israelita Albert EinsteinSão Paulo 05652900Brazil Department of Oncology Hospital do CoraçãoSao Paulo 04004030Brazil

Clear cell sarcoma(CCS)is a type of malignant tumor that can arise from tendons and *** malignant proliferation of cells with melanocytic lineage normally occurs in young patients,and it is normally identified in ***,different sites including gastrointestinal organs are also *** difficulties in the molecular and histopathology evaluation,the diagnosis is often confused with malignant *** cases are treated with surgical resection,but overall,the prognosis is *** this editorial,we will discuss a very interesting case of CCS identified in the *** will discuss the literature and controversies in the management of this type of ***,we will address molecular strategies to be incorporated in those cases to better understand the primary location of the ***,future perspectives of the field and new strategies of treatment will be described.

关键词： Clear cell sarcoma Soft tissue sarcoma metastatic cancer Pancreatic cancer Pancreatectomy

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Unplanned hospitalizations for metastatic cancers:The changing patterns of inpatient palliative care,discharge to hospice care,and in-hospital mortality in the United States

引用

Family Medicine and Community Health 2017年第1期5卷 13-28页

作者： Jason L.Salemi Charles C.Chima Kiara K.Spooner Roger J.Zoorob Department of Family and Community Medicine Baylor College of MedicineHoustonTXUSA

Objective:To describe the rates and temporal trends of inpatient end-of-life care among patients hospitalized with metastatic cancer in the United ***:We used data from the Nationwide Inpatient Sample to conduct a cross-sectional analysis of unplanned inpatient hospitalizations of patients aged 18 years or older with metastatic cancer from 2002 to *** logistic regression was used to assess patient-and hospital-level predictors of discharge to hospice care,palliative care,and in-hospital *** trends in outcomes were characterized with use of joinpoint ***:There were an estimated 350,241 unplanned hospitalizations per year of patients with a diagnosis of metastatic *** their inpatient stay,5.8%of patients received palliative care,and among those discharged alive,12.2%were referred to hospice *** rate of inpatient palliative care increased from 2.3%to 13.6%,the rate of discharge to hospice care increased from 4.1%to 15.6%,and the in-hospital mortality rate decreased from more than 14.0%to 9.8%.These patterns were consistent across cancer subtypes,and were most pronounced among patients with extreme risk of ***:Despite increases in the provision of comfort-oriented care to patients with meta-static cancer,few receive such *** recommend screening protocols in hospitals to identify patients who are good candidates for palliative care consultation and hospice referral.

关键词： End-of-life hospice care inpatient mortality metastatic cancer palliative care unplanned hospitalization

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Inferior mesenteric arteriovenous fistula during treatment with bevacizumab in colorectal cancer patient: A case report

引用

World Journal of Gastrointestinal Oncology 2020年第11期12卷 1364-1371页

作者： Ayako Doi Hiroyuki Takeda Kumiko Umemoto Ryosuke Oumi Shinji Wada Shingo Hamaguchi Hidefumi Mimura Hiroyuki Arai Yoshiki Horie Takuro Mizukami Naoki Izawa Takashi Ogura Takako EguchiNakajima Yu Sunakawa Department of Clinical Oncology St.Marianna University School of MedicineKanagawa 216-8511Japan Department of Gastroenterology St.Marianna University School of MedicineKanagawa 216-8511Japan Department of Radiology St.Marianna University School of MedicineKanagawa 216-8511Japan Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy Kyoto University HospitalKyoto 606-8507Japan

BACKGROUND Fistula formation is a severe adverse event related to antiangiogenetic agents such as bevacizumab and inferior mesenteric arteriovenous fistula(IMAVF) is a result of acquired factor, especially colon surgery. However, IMAVF occurs very rarely and there are few reports in patients during chemotherapy. We report a case of a patient who developed IMAVF during treatment with bevacizumab in metastatic colorectal cancer(mCRC) after colon *** SUMMARY An 81-year-old man was diagnosed with descending colon cancer and underwent left hemicolectomy without any complications. He was definitely diagnosed with high-risk stage 2 and received tegafur-uracil plus leucovorin as adjuvant chemotherapy. Three years and 6 mo after the operation, the cancer relapsed with peritoneal dissemination. The patient underwent CyberKnife radiosurgery targeting the recurrent tumor and received chemotherapy with S-1 plus bevacizumab. At 1 year after chemotherapy, he complained of severe diarrhea, which is suspected drug-induced colitis. As diarrhea worsened despite the termination of treatment, he underwent colonoscopy and computed tomography (CT) scans that revealed edematous change from sigmoid to rectosigmoid colon. CT scans also revealed an aneurysm adjacent to the inferior mesenteric vein and multidetector CT angiography showed the IMAVF. Elective angiography confirmed the diagnosis of an IMAVF and it was successfully treated by arterial embolization. The patient resumed chemotherapy with only S-1 6 mo after *** Clinicians should keep in mind the probability of severe diarrhea arose from IMAVF in mCRC patients treated with bevacizumab.

关键词： metastatic cancer Colon surgery Chemotherapy Fistula formation Inferior mesenteric artery Interventional radiology Case report

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

SURGICAL TREATMENT OF metastatic SPINAL TUMOR

引用

Chinese Medical Sciences Journal 2002年第3期17卷 183-188页

作者：徐宏光王以朋邱贵兴叶启彬张嘉 Department of Orthopedic Surgery Peking Union Medical College Hospital CAMS & PUMC Beijing 100730.

关键词： metastatic cancer spinal pain neurologic deficit surgery Objectives. To evaluate the effect of surgical treatment on metastatic spinal tumor.Methods. The results of surgical intervention for metastatic spinal tumor of 31 consecutive

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：